{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:15:07Z","timestamp":1793823307615,"version":"4.6.1"},"reference-count":155,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mater Sci: Mater Med"],"DOI":"10.1007\/s10856-025-06868-5","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T23:36:23Z","timestamp":1741131383000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Oral dosage forms for drug delivery to the colon: an existing gap between research and commercial applications"],"prefix":"10.1007","volume":"36","author":[{"given":"Estefan\u00eda","family":"Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Gamboa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla V.","family":"Finkielstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Isabel","family":"Ca\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlon Andr\u00e9s","family":"Osorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yesid","family":"V\u00e9lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00e9stor","family":"Llinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8994-597X","authenticated-orcid":false,"given":"Cristina Isabel","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"key":"6868_CR1","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3389\/fphar.2020.00524","volume":"11","author":"S Hua","year":"2020","unstructured":"Hua S. Advances in oral drug delivery for regional targeting in the gastrointestinal tract\u2014influence of physiological, pathophysiological and pharmaceutical factors. Front Pharm. 2020;11:524.","journal-title":"Front Pharm"},{"key":"6868_CR2","doi-asserted-by":"crossref","unstructured":"Alqahtani MS, Kazi M, Alsenaidy MA, Ahmad MZ. Advances in Oral Drug Delivery. Front Pharmacol. 2021;12:618411.","DOI":"10.3389\/fphar.2021.618411"},{"key":"6868_CR3","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/00003088-200241090-00003","volume":"41","author":"H Zhang","year":"2002","unstructured":"Zhang H, Zhang J, Streisand JB. Oral mucosal drug delivery. Clin Pharmacokinet. 2002;41:661\u201380.","journal-title":"Clin Pharmacokinet"},{"key":"6868_CR4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3390\/pharmaceutics9040041","volume":"9","author":"L Lin","year":"2017","unstructured":"Lin L, Wong H. Predicting oral drug absorption: mini review on physiologically-based pharmacokinetic models. Pharmaceutics 2017;9:41.","journal-title":"Pharmaceutics"},{"key":"6868_CR5","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4103\/japtr.JAPTR_26_19","volume":"10","author":"N Belali","year":"2019","unstructured":"Belali N, Wathoni N, Muchtaridi M. Advances in orally targeted drug delivery to colon. J Adv Pharm Technol Res. 2019;10:100.","journal-title":"J Adv Pharm Technol Res"},{"key":"6868_CR6","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1208\/s12249-015-0350-9","volume":"16","author":"S Amidon","year":"2015","unstructured":"Amidon S, Brown JE, Dave VS. Colon-targeted oral drug delivery systems: design trends and approaches. AAPS PharmSciTech. 2015;16:731\u201341.","journal-title":"AAPS PharmSciTech"},{"key":"6868_CR7","first-page":"100943","volume":"19","author":"B Zheng","year":"2024","unstructured":"Zheng B, Wang L, Yi Y, Yin J, Liang A. Design strategies, advances and future perspectives of colon-targeted delivery systems for the treatment of inflammatory bowel disease. Asian J Pharm Sci. 2024;19:100943.","journal-title":"Asian J Pharm Sci"},{"key":"6868_CR8","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/s44222-022-00006-4","volume":"1","author":"X Zhang","year":"2023","unstructured":"Zhang X, Chen G, Zhang H, Shang L, Zhao Y. Bioinspired oral delivery devices. Nat Rev Bioeng 2023;1:208\u201325.","journal-title":"Nat Rev Bioeng"},{"key":"6868_CR9","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1080\/00914037.2020.1785455","volume":"70","author":"MK Sarangi","year":"2021","unstructured":"Sarangi MK, Rao MEB, Parcha V. Smart polymers for colon targeted drug delivery systems: a review. Int J Polym Mater Polym Biomater. 2021;70:1130\u201366.","journal-title":"Int J Polym Mater Polym Biomater"},{"key":"6868_CR10","doi-asserted-by":"crossref","first-page":"540","DOI":"10.2174\/1381612826666200917143816","volume":"27","author":"PHL Tran","year":"2021","unstructured":"Tran PHL, Tran TTD. Mucoadhesive formulation designs for oral controlled drug release at the colon. Curr Pharm Des. 2021;27:540\u20137.","journal-title":"Curr Pharm Des"},{"key":"6868_CR11","doi-asserted-by":"crossref","first-page":"100173","DOI":"10.1016\/j.medidd.2023.100173","volume":"21","author":"S Kumari Singh","year":"2024","unstructured":"Kumari Singh S, Solanki R, Patel S. Nano pharmaceutical delivery in combating colorectal cancer. Med Drug Discov. 2024;21:100173.","journal-title":"Med Drug Discov"},{"key":"6868_CR12","unstructured":"Bahl D, Crowley KJ, Yu D. Solid oral dosage form containing nanoparticles and process for its formulation using fish jelly. Spain; 2010."},{"key":"6868_CR13","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/ibd\/izy123","volume":"24","author":"M Zhang","year":"2018","unstructured":"Zhang M, Merlin D. Nanoparticle-based oral drug delivery systems targeting the colon for treatment of ulcerative colitis. Inflamm Bowel Dis. 2018;24:1401\u201315.","journal-title":"Inflamm Bowel Dis"},{"key":"6868_CR14","unstructured":"Wyeth Pharmaceuticals Inc. Medication Guide: RAPAMUNE\u00ae (RAAP-a-mune) Tablets. Philadelphia; 2010. https:\/\/labeling.pfizer.com\/showlabeling.aspx?id=508."},{"key":"6868_CR15","unstructured":"Filipcsei G, \u00d6tv\u00f6s Z, Heltovics G, Darvas F. Nanostructured aprepitant compositions, process for the preparation thereof and pharmaceutical compositions containing them. European Patent Office; 2011."},{"key":"6868_CR16","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios. EMEND 125 mg c\u00e1psulas duras. The Netherlands, 2008. https:\/\/cima.aemps.es\/cima\/dochtml\/p\/03262006\/P_03262006.html."},{"key":"6868_CR17","unstructured":"Ryde T, Gustow E, Ruddy S, Jain R, Patel R, Wilkins M. Nanoparticulate fibrate formulations. United States, 2007."},{"key":"6868_CR18","unstructured":"Lemasson O, Bourgeois S, Bourgeaux V. Nanoencapsulation: a new era for oral solid dosage forms. ONdrug Delivery; 2022. p. 16\u201320."},{"key":"6868_CR19","unstructured":"United Nations. Department of Economic and Social Affairs. Central Product Classification (CPC). 2015. p. 600."},{"key":"6868_CR20","unstructured":"Cooperative Patent Classification. CPC Scheme and Definitions, 2024."},{"key":"6868_CR21","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/jcm13010040","volume":"13","author":"R Marcellinaro","year":"2023","unstructured":"Marcellinaro R, Spoletini D, Grieco M, Avella P, Cappuccio M, Troiano R, et al. Colorectal cancer: current updates and future perspectives. J Clin Med. 2023;13:40.","journal-title":"J Clin Med"},{"key":"6868_CR22","first-page":"17","volume":"5","author":"S Alatab","year":"2020","unstructured":"Alatab S, Sepanlou SG, Ikuta K, Vahedi H, Bisignano C, Safiri S, et al. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. Gastroenterol Hepatol. 2020;5:17\u201330.","journal-title":"Gastroenterol Hepatol"},{"key":"6868_CR23","first-page":"33","volume":"6","author":"AE M\u2019koma","year":"2013","unstructured":"M\u2019koma AE. Inflammatory bowel disease: an expanding global health problem. Clin Med Insights Gastroenterol. 2013;6:33\u201347.","journal-title":"Clin Med Insights Gastroenterol"},{"key":"6868_CR24","doi-asserted-by":"crossref","unstructured":"Horner R. The world needs pharmaceuticals from China and India to beat coronavirus. The Conversation. 2020.","DOI":"10.64628\/AB.drptngnvx"},{"key":"6868_CR25","doi-asserted-by":"crossref","unstructured":"Jones TM. Preformulation studies. In: Pharmaceutical formulation: the science and technology of dosage forms. Cambridge: Royal Society of Chemistry; 2018.","DOI":"10.1039\/9781782620402-00001"},{"key":"6868_CR26","first-page":"2015","volume":"11","author":"D Yao","year":"2021","unstructured":"Yao D, Yu L, He W, Hu Y, Xu H, Yuan Y, et al. Antineoplastic prescription among patients with colorectal cancer in eight major cities of China, 2015-2019: an observational retrospective database analysis. BMJ Open. 2021;11:2015\u20139.","journal-title":"BMJ Open"},{"key":"6868_CR27","first-page":"243","volume":"50","author":"MD Long","year":"2017","unstructured":"Long MD, Kappelman MD, Martin CF, Chen W, Anton K, Sandler RS. Role of non-steroidal anti-inflammatory drug in exacerbations of inflammatory bowel disease. J Clin Gastroenterol. 2017;50:243\u201358.","journal-title":"J Clin Gastroenterol"},{"key":"6868_CR28","doi-asserted-by":"crossref","unstructured":"Kafil TS, Nguyen TM, MacDonald JK, Chande N. Cannabis for the treatment of ulcerative colitis. Cochrane Database Syst Rev. 2018;11:CD012954.","DOI":"10.1002\/14651858.CD012954"},{"key":"6868_CR29","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1021\/acs.molpharmaceut.1c00086","volume":"18","author":"A Ranjan","year":"2021","unstructured":"Ranjan A, Jha PK. Studying drug release through polymeric controlled release formulations in United States pharmacopoeia 2 apparatus using multiphysics simulation and experiments. Mol Pharm. 2021;18:2600\u201311.","journal-title":"Mol Pharm"},{"key":"6868_CR30","doi-asserted-by":"crossref","first-page":"132129","DOI":"10.1016\/j.molstruc.2021.132129","volume":"1252","author":"SA Algharib","year":"2022","unstructured":"Algharib SA, Dawood A, Zhou K, Chen D, Li C, Meng K, et al. Preparation of chitosan nanoparticles by ionotropic gelation technique: effects of formulation parameters and in vitro characterization. J Mol Struct. 2022;1252:132129.","journal-title":"J Mol Struct"},{"key":"6868_CR31","doi-asserted-by":"crossref","unstructured":"Chen J, Pan S, Zhou J, Lin Z, Qu Y, Glab A, et al. Assembly of Bioactive Nanoparticles via Metal-Phenolic Complexation. Adv Mater. 2022;34:e2108624.","DOI":"10.1002\/adma.202108624"},{"key":"6868_CR32","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1039\/C9RA10857B","volume":"10","author":"KY Hern\u00e1ndez-Giottonini","year":"2020","unstructured":"Hern\u00e1ndez-Giottonini KY, Rodr\u00edguez-C\u00f3rdova RJ, Guti\u00e9rrez-Valenzuela CA, Pe\u00f1u\u00f1uri-Miranda O, Zavala-Rivera P, Guerrero-Germ\u00e1n P, et al. PLGA nanoparticle preparations by emulsification and nanoprecipitation techniques: effects of formulation parameters. RSC Adv. 2020;10:4218\u201331.","journal-title":"RSC Adv"},{"key":"6868_CR33","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3390\/pharmaceutics12010068","volume":"12","author":"SH Lee","year":"2020","unstructured":"Lee SH, Bajracharya R, Min JY, Han JW, Park BJ, Han HK. Strategic approaches for colon targeted drug delivery: an overview of recent advancements. Pharmaceutics 2020;12:68.","journal-title":"Pharmaceutics"},{"key":"6868_CR34","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ijpharm.2019.01.066","volume":"559","author":"MNU Nguyen","year":"2019","unstructured":"Nguyen MNU, Tran PHL, Tran TTD. A single-layer film coating for colon-targeted oral delivery. Int J Pharm. 2019;559:402\u20139.","journal-title":"Int J Pharm"},{"key":"6868_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2018.00001","volume":"9","author":"DW Liu","year":"2018","unstructured":"Liu DW, Yan H, Kong Y, You Y, Li Y, Wang L, et al. Preparation of colon-targeted acetylharpagide tablets and its release properties in vivo and in vitro. Front Pharm. 2018;9:1\u20139.","journal-title":"Front Pharm"},{"key":"6868_CR36","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2147\/DDDT.S123412","volume":"11","author":"MS Kim","year":"2017","unstructured":"Kim MS, Yeom DW, Kim SR, Yoon HY, Kim CH, Son HY, et al. Development of a chitosan based double layer-coated tablet as a platform for colon-specific drug delivery. Drug Des Devel Ther. 2017;11:45\u201357.","journal-title":"Drug Des Devel Ther"},{"key":"6868_CR37","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jconrel.2017.07.043","volume":"262","author":"T Chen","year":"2017","unstructured":"Chen T, Li J, Chen T, Sun CC, Zheng Y. Tablets of multi-unit pellet system for controlled drug delivery. J Control Release. 2017;262:222\u201331.","journal-title":"J Control Release"},{"key":"6868_CR38","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3390\/pharmaceutics10040176","volume":"10","author":"N Al-Hashimi","year":"2018","unstructured":"Al-Hashimi N, Begg N, Alany RG, Hassanin H, Elshaer A. Oral modified release multiple-unit particulate systems: compressed pellets, microparticles and nanoparticles. Pharmaceutics 2018;10:176.","journal-title":"Pharmaceutics"},{"key":"6868_CR39","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ejps.2017.03.006","volume":"102","author":"HJ Park","year":"2017","unstructured":"Park HJ, Jung HJ, Ho MJ, Lee DR, Cho HR, Choi YS, et al. Colon-targeted delivery of solubilized bisacodyl by doubly enteric-coated multiple-unit tablet. Eur J Pharm Sci. 2017;102:172\u20139.","journal-title":"Eur J Pharm Sci"},{"key":"6868_CR40","unstructured":"Warnke G, Carpanzano T. Layer by layer: the fundamentals of multi-layer tableting. JRS Pharma; 2021."},{"key":"6868_CR41","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2478\/cipms-2019-0039","volume":"32","author":"T Blicharski","year":"2019","unstructured":"Blicharski T, Swiader K, Serefko A, Kulczycka-Mamona S, Kolodziejczyk M, Szopa A. Challenges in technology of bilayer and multi-layer tablets: a mini-review. Curr Issues Pharm Med Sci. 2019;32:229\u201335.","journal-title":"Curr Issues Pharm Med Sci"},{"key":"6868_CR42","first-page":"238","volume":"7","author":"R Akter","year":"2018","unstructured":"Akter R, Habibur Rahman M, Khairul Islam M, Islam R, Maharin Shapla M. An innovative approach of special layered tablet technology. World J Pharm Pharm Sci SJIF Impact Factor. 2018;7:238.","journal-title":"World J Pharm Pharm Sci SJIF Impact Factor"},{"key":"6868_CR43","first-page":"569470","volume":"2013","author":"Z Khan","year":"2013","unstructured":"Khan Z, Choonara YE, Kumar P, Du Toit LC, Ndesendo VMK, Pillay V. A novel multilayered multidisk oral tablet for chronotherapeutic drug delivery. Biomed Res Int. 2013;2013:569470.","journal-title":"Biomed Res Int"},{"key":"6868_CR44","first-page":"872","volume":"9","author":"S More","year":"2018","unstructured":"More S, Ghodekar S, Rane B, Bavaskar K, Patil M, Jain A. Multilayered tablet: a novel approach for oral drug delivery. Int J Pharm Sci Res. 2018;9:872\u201382.","journal-title":"Int J Pharm Sci Res"},{"key":"6868_CR45","doi-asserted-by":"crossref","first-page":"7392","DOI":"10.1158\/0008-5472.CAN-10-2027","volume":"70","author":"KR Patel","year":"2010","unstructured":"Patel KR, Brown VA, Jones DJL, Britton RG, Hemingway D, Miller AS, et al. Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res. 2010;70:7392\u20139.","journal-title":"Cancer Res"},{"key":"6868_CR46","unstructured":"Dash AK. Solid dosage forms. In: Dash AK, Singh S, Tolman J, editors. Pharmaceutics-basic principles and application to pharmacy practice. San Diego: Academic Press; 2014. pp. 165\u2013168."},{"key":"6868_CR47","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.3390\/ma13071771","volume":"13","author":"B Maciejewski","year":"2020","unstructured":"Maciejewski B, Arumughan V, Larsson A, Sznitowska M. Prototype gastro-resistant soft gelatin films and capsules-imaging and performance in vitro. Materials 2020;13:1771.","journal-title":"Materials"},{"key":"6868_CR48","unstructured":"Sydow G, Sennhauser M, Schluetermann B, Prasch A, Nehring R. Gastro-resistant soft shell capsule and process for its manufacture. European Patent Office; 2014."},{"key":"6868_CR49","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ejpb.2019.09.015","volume":"144","author":"JAC Barbosa","year":"2019","unstructured":"Barbosa JAC, Al-Kauraishi MM, Smith AM, Conway BR, Merchant HA. Achieving gastroresistance without coating: formulation of capsule shells from enteric polymers. Eur J Pharm Biopharm. 2019;144:174\u20139.","journal-title":"Eur J Pharm Biopharm"},{"key":"6868_CR50","first-page":"54","volume":"2","author":"DK Singh","year":"2011","unstructured":"Singh DK, Poddar AS, Nigade SU, Poddar SS. Pulsatile drug delivery system: an overview. Int J Curr Pharm Rev Res. 2011;2:54\u201380.","journal-title":"Int J Curr Pharm Rev Res"},{"key":"6868_CR51","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1023\/A:1011940718534","volume":"15","author":"I Kr\u00f6gel","year":"1998","unstructured":"Kr\u00f6gel I, Bodmeier R. Pulsatile drug release from an insoluble capsule body controlled by an erodible plug. Pharm Res. 1998;15:474\u201381.","journal-title":"Pharm Res"},{"key":"6868_CR52","doi-asserted-by":"crossref","first-page":"22280","DOI":"10.1039\/C6RA27693H","volume":"7","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Bai Y, Chen H, Huang Y, Yuan P, Zhang L. Preparation of a colon-specific sustained-release capsule with curcumin-loaded SMEDDS alginate beads. RSC Adv. 2017;7:22280\u20135.","journal-title":"RSC Adv"},{"key":"6868_CR53","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1080\/01635581.2019.1659380","volume":"72","author":"F Haidari","year":"2019","unstructured":"Haidari F, Abiri B, Iravani M, Ahmadi-Angali K, Vafa M. Effects of vitamin D and omega-3 fatty acids co-supplementation on inflammatory factors and tumor marker CEA in colorectal cancer patients undergoing chemotherapy: a randomized, double-blind, placebo-controlled clinical trial. Nutr Cancer. 2019;72:948\u201358.","journal-title":"Nutr Cancer"},{"key":"6868_CR54","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3390\/cells8060523","volume":"8","author":"G Fiorino","year":"2019","unstructured":"Fiorino G, Sturniolo GC, Bossa F, Cassinotti A, Di Sabatino A, Giu P, et al. A phase 2a, multicenter, randomized, double-blind, parallel-group, placebo-controlled trial of IBD98-M delayed-release capsules to induce remission in patients with active and mild to moderate ulcerative colitis. Cells 2019;8:523.","journal-title":"Cells"},{"key":"6868_CR55","doi-asserted-by":"crossref","unstructured":"Bhaw-Luximon A, Goonoo N, Jhurry D. Nanotherapeutics promises for colorectal cancer and pancreatic ductal adenocarcinoma. In: Grumezescu AM, editor. Nanobiomaterials in cancer therapy. Elsevier; 2016. pp. 147\u2013201.","DOI":"10.1016\/B978-0-323-42863-7.00006-2"},{"key":"6868_CR56","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3390\/pharmaceutics16030431","volume":"16","author":"P Garbati","year":"2024","unstructured":"Garbati P, Picco C, Magrassi R, Signorello P, Cacopardo L, Dalla Serra M, et al. Targeting the gut: a systematic review of specific drug nanocarriers. Pharmaceutics 2024;16:431.","journal-title":"Pharmaceutics"},{"key":"6868_CR57","doi-asserted-by":"crossref","first-page":"123735","DOI":"10.1016\/j.ijpharm.2023.123735","volume":"651","author":"I Shazleen Ibrahim","year":"2024","unstructured":"Shazleen Ibrahim I, Starlin Chellathurai M, Mahmood S, Hakim Azmi A, Harun N, Ulul Ilmie Ahmad Nazri M, et al. Engineered liposomes mediated approach for targeted colorectal cancer drug delivery: a review. Int J Pharm. 2024;651:123735.","journal-title":"Int J Pharm"},{"key":"6868_CR58","first-page":"144","volume":"22","author":"KS Italiya","year":"2021","unstructured":"Italiya KS, Singh AK, Chitkara D, Mittal A. Nanoparticulate tablet dosage form of lisofylline-linoleic acid conjugate for type 1 diabetes: in situ single-pass intestinal perfussion (SPIP) studies and pharmacokinetics in rat. Am Assoc Pharm Sci. 2021;22:144.","journal-title":"Am Assoc Pharm Sci"},{"key":"6868_CR59","doi-asserted-by":"crossref","first-page":"119482","DOI":"10.1016\/j.ijpharm.2020.119482","volume":"586","author":"T Shanmugam","year":"2020","unstructured":"Shanmugam T, Joshi N, Ahamad N, Deshmukh A, Banerjee R. Enhanced absorption, and efficacy of oral self-assembled paclitaxel nanocochleates in multi-drug resistant colon cancer. Int J Pharm. 2020;586:119482.","journal-title":"Int J Pharm"},{"key":"6868_CR60","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/15347354221105498","volume":"21","author":"Y Jeon","year":"2022","unstructured":"Jeon Y, Sym SJ, Yoo BK, Baek JH. Long-term survival, tolerability, and safety of first-line bevacizumab and FOLFIRI in combination with ginsenoside-modified nanostructured lipid carrier containing curcumin in patients with unresectable metastatic colorectal cancer. Integr Cancer Ther. 2022;21:4\u201310.","journal-title":"Integr Cancer Ther"},{"key":"6868_CR61","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.2174\/092986706778201648","volume":"13","author":"H Kalasz","year":"2006","unstructured":"Kalasz H, Antal I. Drug excipients. Curr Med Chem. 2006;13:2535\u201363.","journal-title":"Curr Med Chem"},{"key":"6868_CR62","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1517\/17425247.2013.736962","volume":"10","author":"S Thakral","year":"2013","unstructured":"Thakral S, Thakral NK, Majumdar DK. Eudragit\u00ae: a technology evaluation. Expert Opin Drug Deliv. 2013;10:131\u201349.","journal-title":"Expert Opin Drug Deliv"},{"key":"6868_CR63","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2125.1982.tb01999.x","volume":"14","author":"MJ Dew","year":"1982","unstructured":"Dew MJ, Hughes PJ, Lee MG, Evans BK, Rhodes J. An oral preparation to release drugs in the human colon. Br J Clin Pharmacol. 1982;14:405\u20138.","journal-title":"Br J Clin Pharmacol"},{"key":"6868_CR64","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3390\/ma8030832","volume":"8","author":"MB Subudhi","year":"2015","unstructured":"Subudhi MB, Jain A, Jain A, Hurkat P, Shilpi S, Gulbake A, et al. Eudragit S100 coated citrus pectin nanoparticles for colon targeting of 5-fluorouracil. Materials 2015;8:832\u201349.","journal-title":"Materials"},{"key":"6868_CR65","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1208\/s12249-016-0594-z","volume":"18","author":"S Chen","year":"2017","unstructured":"Chen S, Guo F, Deng T, Zhu S, Liu W, Zhong H, et al. Eudragit S100-coated chitosan nanoparticles co-loading tat for enhanced oral colon absorption of insulin. AAPS PharmSciTech. 2017;18:1277\u201387.","journal-title":"AAPS PharmSciTech"},{"key":"6868_CR66","doi-asserted-by":"crossref","DOI":"10.1186\/s13568-017-0442-x","volume":"7","author":"F Ansari","year":"2017","unstructured":"Ansari F, Pourjafar H, Jodat V, Sahebi J, Ataei A. Effect of Eudragit S100 nanoparticles and alginate chitosan encapsulation on the viability of Lactobacillus acidophilus and Lactobacillus rhamnosus. AMB Express. 2017;7:144.","journal-title":"AMB Express"},{"key":"6868_CR67","doi-asserted-by":"crossref","first-page":"6409","DOI":"10.1021\/acsanm.9b01377","volume":"2","author":"A Sood","year":"2019","unstructured":"Sood A, Dev A, Mohanbhai SJ, Shrimali N, Kapasiya M, Kushwaha AC, et al. Disulfide-bridged chitosan-Eudragit S-100 nanoparticles for colorectal cancer. ACS Appl Nano Mater. 2019;2:6409\u201317.","journal-title":"ACS Appl Nano Mater"},{"key":"6868_CR68","doi-asserted-by":"crossref","first-page":"105019","DOI":"10.1016\/j.ejps.2019.105019","volume":"138","author":"C Maderuelo","year":"2019","unstructured":"Maderuelo C, Lanao JM, Zarzuelo A. Enteric coating of oral solid dosage forms as a tool to improve drug bioavailability. Eur J Pharm Sci. 2019;138:105019.","journal-title":"Eur J Pharm Sci"},{"key":"6868_CR69","doi-asserted-by":"crossref","unstructured":"Dias F, Duarte C. Cellulose and its derivatives use in the pharmaceutical compounding practice. In: Cellulose\u2013medical, pharmaceutical and electronic applications. Rijeka: InTech; 2013. pp. 141\u2013162.","DOI":"10.5772\/56637"},{"key":"6868_CR70","doi-asserted-by":"crossref","first-page":"11797","DOI":"10.1021\/ie201623d","volume":"50","author":"K Ganguly","year":"2011","unstructured":"Ganguly K, Aminabhavi TM, Kulkarni AR. Colon targeting of 5-fluorouracil using polyethylene glycol cross-linked chitosan microspheres enteric coated with cellulose acetate phthalate. Ind Eng Chem Res. 2011;50:11797\u2013807.","journal-title":"Ind Eng Chem Res"},{"key":"6868_CR71","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2174\/1389201033489748","volume":"4","author":"Y Kato","year":"2005","unstructured":"Kato Y, Onishi H, Machida Y. Application of chitin and chitosan derivatives in the pharmaceutical field. Curr Pharm Biotechnol. 2005;4:303\u20139.","journal-title":"Curr Pharm Biotechnol"},{"key":"6868_CR72","doi-asserted-by":"crossref","first-page":"855","DOI":"10.4155\/tde.15.31","volume":"6","author":"JA Jennings","year":"2015","unstructured":"Jennings JA, Wells CM, McGraw GS, Velasquez Pulgarin DA, Whitaker MD, Pruitt RL, et al. Chitosan coatings to control release and target tissues for therapeutic delivery. Ther Deliv. 2015;6:855\u201371.","journal-title":"Ther Deliv"},{"key":"6868_CR73","doi-asserted-by":"crossref","unstructured":"Dalmoro A, Barba AA, Lamberti G, Grassi M, d'Amore M. Pharmaceutical applications of biocompatible polymer blends containing sodium alginate\u2020. Adv Polym Technol. 2012;31:219\u201330.","DOI":"10.1002\/adv.21276"},{"key":"6868_CR74","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1081\/DDC-120003853","volume":"28","author":"HH T\u00f8nnesen","year":"2002","unstructured":"T\u00f8nnesen HH, Karlsen J. Alginate in drug delivery systems. Drug Dev Ind Pharm. 2002;28:621\u201330.","journal-title":"Drug Dev Ind Pharm"},{"key":"6868_CR75","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1163\/156856295X00814","volume":"7","author":"R Narayani","year":"1995","unstructured":"Narayani R, Rao KP. Polymer-coated gelatin capsules as oral delivery devices and their gastrointestinal tract behaviour in humans. J Biomater Sci Polym Ed. 1995;7:39\u201348.","journal-title":"J Biomater Sci Polym Ed"},{"key":"6868_CR76","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijpharm.2011.10.045","volume":"422","author":"M Rabi\u0161kov\u00e1","year":"2012","unstructured":"Rabi\u0161kov\u00e1 M, Bautzov\u00e1 T, Gajdziok J, Dvo\u0159\u00e1\u010dkov\u00e1 K, Lamprecht A, Pellequer Y, et al. Coated chitosan pellets containing rutin intended for the treatment of inflammatory bowel disease: in vitro characteristics and in vivo evaluation. Int J Pharm. 2012;422:151\u20139.","journal-title":"Int J Pharm"},{"key":"6868_CR77","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijpharm.2017.03.053","volume":"524","author":"RI Moustafine","year":"2017","unstructured":"Moustafine RI, Sitenkov AY, Bukhovets AV, Nasibullin SF, Appeltans B, Kabanova TV, et al. Indomethacin-containing interpolyelectrolyte complexes based on Eudragit\u00ae E PO\/S 100 copolymers as a novel drug delivery system. Int J Pharm. 2017;524:121\u201333.","journal-title":"Int J Pharm"},{"key":"6868_CR78","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2174\/1567201818666210805153347","volume":"19","author":"M Sher","year":"2022","unstructured":"Sher M, Sarfaraz RM, Iqbal S, Hussain MA, Naeem-ul Hassan M, Hassan F, et al. Formulation and evaluation of hydroxypropylmethylcellulose-dicyclomine microsponges for colon targeted drug delivery: in vitro and in vivo evaluation. Curr Drug Deliv. 2022;19:686\u201396. https:\/\/pubmed.ncbi.nlm.nih.gov\/34353263\/.","journal-title":"Curr Drug Deliv"},{"key":"6868_CR79","doi-asserted-by":"crossref","unstructured":"Debotton N, Dahan A. Applications of Polymers as Pharmaceutical Excipients in Solid Oral Dosage Forms. Med Res Rev. 2017;37:52\u201397.","DOI":"10.1002\/med.21403"},{"key":"6868_CR80","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.2174\/1567201818666210708121739","volume":"18","author":"M Shaikn","year":"2021","unstructured":"Shaikn M, Desai N, Momin M, Kumar Bhatt L. Formulation development and in-vitro\/ex-vivo evaluation for a polysaccharide-based colon targeted matrix tablet. Curr Drug Deliv. 2021;18:1563\u201373.","journal-title":"Curr Drug Deliv"},{"key":"6868_CR81","doi-asserted-by":"crossref","first-page":"626","DOI":"10.4236\/jbnb.2011.225075","volume":"2","author":"C Lovelyn","year":"2011","unstructured":"Lovelyn C, Attama AA. Current state of nanoemulsions in drug delivery. J Biomater Nanobiotechnol. 2011;2:626\u201339.","journal-title":"J Biomater Nanobiotechnol"},{"key":"6868_CR82","doi-asserted-by":"crossref","first-page":"43","DOI":"10.15415\/jptrm.2013.11004","volume":"1","author":"BS Sekhon","year":"2013","unstructured":"Sekhon BS. Surfactants: pharmaceutical and medicinal aspects. J Pharm Technol Res Manag. 2013;1:43\u201368.","journal-title":"J Pharm Technol Res Manag"},{"key":"6868_CR83","doi-asserted-by":"crossref","first-page":"520","DOI":"10.2174\/1570180819666220124113436","volume":"19","author":"S Dharwal","year":"2022","unstructured":"Dharwal S, Bajwa N, Madan J, Mandar UK, Singh KK, Baldi A. Self-double emulsified drug delivery system of pyridostigmine bromide augmented permeation across caco-2 cells. Lett Drug Des Discov. 2022;19:520\u20139.","journal-title":"Lett Drug Des Discov"},{"key":"6868_CR84","doi-asserted-by":"crossref","first-page":"122123","DOI":"10.1016\/j.ijpharm.2022.122123","volume":"625","author":"M Liu","year":"2022","unstructured":"Liu M, Svirskis D, Proft T, Loh J, Chen S, Kang D, et al. Exploring ex vivo peptideolysis of thymopentin and lipid-based nanocarriers towards oral formulations. Int J Pharm. 2022;625:122123.","journal-title":"Int J Pharm"},{"key":"6868_CR85","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1080\/03639045.2017.1414835","volume":"44","author":"Z \u0106etkovi\u0107","year":"2018","unstructured":"\u0106etkovi\u0107 Z, Cviji\u0107 S, Vasiljevi\u0107 D. In vitro\/in silico approach in the development of simvastatin-loaded self-microemulsifying drug delivery systems. Drug Dev Ind Pharm. 2018;44:849\u201360.","journal-title":"Drug Dev Ind Pharm"},{"key":"6868_CR86","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1007\/s11095-017-2129-z","volume":"34","author":"D Markl","year":"2017","unstructured":"Markl D, Zeitler JA. A review of disintegration mechanisms and measurement techniques. Pharm Res. 2017;34:890\u2013917.","journal-title":"Pharm Res"},{"key":"6868_CR87","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3390\/powders2010008","volume":"2","author":"CG Jange","year":"2023","unstructured":"Jange CG, Wassgren CR, Ambrose K. The significance of tablet internal structure on disintegration and dissolution of immediate-release formulas: a review. Powders. 2023;2:99\u2013123.","journal-title":"Powders"},{"key":"6868_CR88","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3390\/pharmaceutics15020489","volume":"15","author":"M Soundaranathan","year":"2023","unstructured":"Soundaranathan M, Al-Sharabi M, Sweijen T, Bawuah P, Zeitler JA, Hassanizadeh SM, et al. Modelling the evolution of pore structure during the disintegration of pharmaceutical tablets. Pharmaceutics 2023;15:489.","journal-title":"Pharmaceutics"},{"key":"6868_CR89","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1080\/17425247.2020.1788541","volume":"17","author":"S Wang","year":"2020","unstructured":"Wang S, Liu R, Fu Y, Kao WJ. Release mechanisms and applications of drug delivery systems for extended-release. Expert Opin Drug Deliv. 2020;17:1289\u2013304.","journal-title":"Expert Opin Drug Deliv"},{"key":"6868_CR90","doi-asserted-by":"crossref","first-page":"70","DOI":"10.5001\/omj.2010.24","volume":"25","author":"AK Philip","year":"2010","unstructured":"Philip AK, Philip B. Colon targeted drug delivery systems: a review on primary and novel approaches. Oman Med J 2010;25:70\u20138.","journal-title":"Oman Med J"},{"key":"6868_CR91","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.3390\/ijms21061917","volume":"21","author":"F Casati","year":"2020","unstructured":"Casati F, Melocchi A, Moutaharrik S, Uboldi M, Foppoli A, Maroni A, et al. Injection molded capsules for colon delivery combining time-controlled and enzyme-triggered approaches. Int J Mol Sci. 2020;21:1917.","journal-title":"Int J Mol Sci"},{"key":"6868_CR92","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3390\/pr10061094","volume":"10","author":"P Trucillo","year":"2022","unstructured":"Trucillo P. Drug carriers: a review on the most used mathematical models for drug release. Processes. 2022;10:1094.","journal-title":"Processes"},{"key":"6868_CR93","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3390\/polym12051105","volume":"12","author":"A Geraili","year":"2020","unstructured":"Geraili A, Mequanint K. Systematic studies on surface erosion of photocrosslinked polyanhydride tablets and data correlation with release kinetic models. Polymers. 2020;12:1105.","journal-title":"Polymers"},{"key":"6868_CR94","unstructured":"BDD World Class Drug Delivery Company. https:\/\/www.bddpharma.com\/technologies\/cologik\/. CologiKTM. 2025."},{"key":"6868_CR95","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.3390\/pharmaceutics14122762","volume":"14","author":"A Gazzaniga","year":"2022","unstructured":"Gazzaniga A, Moutaharrik S, Filippin I, Foppoli A, Palugan L, Maroni A, et al. Time-based formulation strategies for colon drug delivery. Pharmaceutics 2022;14:2762.","journal-title":"Pharmaceutics"},{"key":"6868_CR96","doi-asserted-by":"crossref","unstructured":"Bisotti F, Pizzetti F, Storti G, Rossi F. Mathematical modelling of cross-linked polyacrylic-based hydrogels: physical properties and drug delivery. Drug Deliv Transl Res. 2022;12:1928\u201342.","DOI":"10.1007\/s13346-022-01129-2"},{"key":"6868_CR97","doi-asserted-by":"crossref","unstructured":"Bruschi M. Main mechanisms to control the drug release. In: Strategies to modify the drug release from pharmaceutical systems. Woodhead Publishing; 2015. pp. 37\u201362.","DOI":"10.1016\/B978-0-08-100092-2.00004-7"},{"key":"6868_CR98","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.3390\/polym12122921","volume":"12","author":"A Setapa","year":"2020","unstructured":"Setapa A, Ahmad N, Mohd Mahali S, Mohd Amin MCI. Mathematical model for estimating parameters of swelling drug delivery devices in a two-phase release. Polymers. 2020;12:2921.","journal-title":"Polymers"},{"key":"6868_CR99","doi-asserted-by":"crossref","first-page":"122499","DOI":"10.1016\/j.ijpharm.2022.122499","volume":"631","author":"V Doggwiler","year":"2023","unstructured":"Doggwiler V, Lanz M, Paredes V, Lipps G, Imanidis G. Tablet formulation with dual control concept for efficient colonic drug delivery. Int J Pharm. 2023;631:122499.","journal-title":"Int J Pharm"},{"key":"6868_CR100","doi-asserted-by":"crossref","unstructured":"Gouda R, Baishya H, Qing Z. Application of Mathematical Models in Drug Release Kinetics of Carbidopa and Levodopa ER Tablets. J Develop Drugs 2017;6:171.","DOI":"10.4172\/2329-6631.1000171"},{"key":"6868_CR101","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.3390\/ph15111430","volume":"15","author":"Y Almoshari","year":"2022","unstructured":"Almoshari Y. Osmotic pump drug delivery systems\u2014a comprehensive review. Pharmaceuticals 2022;15:1430.","journal-title":"Pharmaceuticals"},{"key":"6868_CR102","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ijpharm.2013.02.032","volume":"457","author":"D Sauer","year":"2013","unstructured":"Sauer D, Cerea M, Dinunzio J, McGinity J. Dry powder coating of pharmaceuticals: a review. Int J Pharm. 2013;457:488\u2013502.","journal-title":"Int J Pharm"},{"key":"6868_CR103","doi-asserted-by":"crossref","unstructured":"Lengyel M, K\u00e1llai-Szab\u00f3 N, Antal V, Laki AJ, Antal I. Microparticles, Microspheres, and Microcapsules for Advanced Drug Delivery. Sci Pharm. 2019;87:20.","DOI":"10.3390\/scipharm87030020"},{"key":"6868_CR104","doi-asserted-by":"crossref","first-page":"5690","DOI":"10.3390\/molecules27175690","volume":"27","author":"R Chen","year":"2022","unstructured":"Chen R, Zhai R, Wang C, Liang S, Wang J, Liu Z, et al. Compound capecitabine colon-targeted microparticle prepared by coaxial electrospray for treatment of colon tumors. Molecules 2022;27:5690.","journal-title":"Molecules"},{"key":"6868_CR105","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejpb.2021.05.002","volume":"165","author":"D Preisig","year":"2021","unstructured":"Preisig D, Varum F, Bravo R, Hartig C, Spleiss J, Abbes S, et al. Colonic delivery of metronidazole-loaded capsules for local treatment of bacterial infections: a clinical pharmacoscintigraphy study. Eur J Pharm Biopharm. 2021;165:22\u201330.","journal-title":"Eur J Pharm Biopharm"},{"key":"6868_CR106","doi-asserted-by":"crossref","first-page":"S733","DOI":"10.5530\/ijper.55.3s.180","volume":"55","author":"HK Dewangan","year":"2021","unstructured":"Dewangan HK, Sharma A, Mishra A, Singour P. Mucoadhesive microspheres of atorvastatin calcium: rational design, evaluation and enhancement of bioavailability. Indian J Pharm Educ Res. 2021;55:S733\u201341.","journal-title":"Indian J Pharm Educ Res"},{"key":"6868_CR107","first-page":"1","volume":"10","author":"Q Cheng","year":"2021","unstructured":"Cheng Q, Liu L, Xie M, Li H, Ma D, Xue W. A colon-targeted oral probiotics delivery system using an enzyme-triggered fuse-like microcapsule. Adv Health Mater 2021;10:1\u201310.","journal-title":"Adv Health Mater"},{"key":"6868_CR108","first-page":"118","volume":"12","author":"BH Jaswanth Gowda","year":"2020","unstructured":"Jaswanth Gowda BH, Shankar SJ, Munisamy M, Akshatha RS, Sagar VS. Development of ph-dependent chronomodulated delivery systems of 5-fluorouracil and oxaliplatin to treat colon cancer. Int J Appl Pharm. 2020;12:118\u201330.","journal-title":"Int J Appl Pharm"},{"key":"6868_CR109","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejpb.2017.11.012","volume":"123","author":"AB Meneguin","year":"2018","unstructured":"Meneguin AB, Beyssac E, Garrait G, Hsein H, Cury BSF. Retrograded starch\/pectin coated gellan gum-microparticles for oral administration of insulin: a technological platform for protection against enzymatic degradation and improvement of intestinal permeability. Eur J Pharm Biopharm. 2018;123:84\u201394.","journal-title":"Eur J Pharm Biopharm"},{"key":"6868_CR110","doi-asserted-by":"crossref","unstructured":"Rajabi-Siahboomi A. Overview of multiparticulate systems for oral drug delivery. In: Rajabi-Siahboomi A, editor. Multiparticulate drug delivery. New York: Springer; 2017. p. 1\u20134.","DOI":"10.1007\/978-1-4939-7012-4_1"},{"key":"6868_CR111","doi-asserted-by":"crossref","unstructured":"Thommes M, Kleinebudde P. The science and practice of extrusion-spheronization. In: Multiparticulate drug delivery. New York: Springer; 2017. p. 37\u201363.","DOI":"10.1007\/978-1-4939-7012-4_3"},{"key":"6868_CR112","doi-asserted-by":"crossref","first-page":"1184472","DOI":"10.3389\/fphar.2023.1184472","volume":"14","author":"M Chaurasia","year":"2023","unstructured":"Chaurasia M, Singh R, Sur S, Flora SJS. A review of FDA approved drugs and their formulations for the treatment of breast cancer. Front Pharmacol. 2023;14:1184472.","journal-title":"Front Pharmacol"},{"key":"6868_CR113","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3390\/pharmaceutics16050674","volume":"16","author":"Q Chen","year":"2024","unstructured":"Chen Q, Yang Z, Liu H, Man J, Oladejo AO, Ibrahim S, et al. Novel drug delivery systems: an important direction for drug innovation research and development. Pharmaceutics 2024;16:674.","journal-title":"Pharmaceutics"},{"key":"6868_CR114","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jconrel.2022.12.029","volume":"353","author":"LE McCoubrey","year":"2023","unstructured":"McCoubrey LE, Favaron A, Awad A, Orlu M, Gaisford S, Basit AW. Colonic drug delivery: formulating the next generation of colon-targeted therapeutics. J Control Release. 2023;353:1107\u201326. Elsevier B.V.","journal-title":"J Control Release"},{"key":"6868_CR115","doi-asserted-by":"crossref","first-page":"e11390","DOI":"10.1016\/j.heliyon.2022.e11390","volume":"8","author":"CE Ugwu","year":"2022","unstructured":"Ugwu CE, Kenechukwu FC, Diovu EO, Udodeme HO, Momoh MA, Onuigbo EB, et al. Exploitation of capsule system for colon targeted drug delivery of biopolymer-based microparticles: in vivo and in vitro applications. Heliyon 2022;8:e11390.","journal-title":"Heliyon"},{"key":"6868_CR116","doi-asserted-by":"crossref","unstructured":"Dos Santos AM, Carvalho SG, Meneguin AB, S\u00e1bio RM, Gremi\u00e3o MPD, Chorilli M. Oral delivery of micro\/nanoparticulate systems based on natural polysaccharides for intestinal diseases therapy: Challenges, advances and future perspectives. J Control Release. 2021;334:353\u201366.","DOI":"10.1016\/j.jconrel.2021.04.026"},{"key":"6868_CR117","doi-asserted-by":"crossref","unstructured":"Kar M, Chourasiya Y, Maheshwari R, Tekade RK. Current developments in excipient science. In: Basic fundamentals of drug delivery. London: Elsevier; 2019. pp. 29\u201383.","DOI":"10.1016\/B978-0-12-817909-3.00002-9"},{"key":"6868_CR118","doi-asserted-by":"crossref","first-page":"66","DOI":"10.36348\/gajpdr.2022.v04i03.003","volume":"4","author":"MsKR Dudhat","year":"2022","unstructured":"Dudhat MsKR. The overview of oral solid dosage forms and different excipients used for solid dosage formulation. Glob Acad J Pharm Drug Res. 2022;4:66\u201372.","journal-title":"Glob Acad J Pharm Drug Res"},{"key":"6868_CR119","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3390\/pharmaceutics12050393","volume":"12","author":"J van der Merwe","year":"2020","unstructured":"van der Merwe J, Steenekamp J, Steyn D, Hamman J. The role of functional excipients in solid oral dosage forms to overcome poor drug dissolution and bioavailability. Pharmaceutics 2020;12:393.","journal-title":"Pharmaceutics"},{"key":"6868_CR120","first-page":"277","volume":"3","author":"SB Somwanshi","year":"2016","unstructured":"Somwanshi SB, Dolas RT, Wagh VD, Kotade KB. Pharmaceutically used plasticizers: a review of biomedical and pharmaceutical sciences. Eur J Biomed Pharm Sci. 2016;3:277\u201385.","journal-title":"Eur J Biomed Pharm Sci"},{"key":"6868_CR121","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.3390\/pharmaceutics14102203","volume":"14","author":"S Tambe","year":"2022","unstructured":"Tambe S, Jain D, Meruva SK, Rongala G, Juluri A, Nihalani G, et al. Recent advances in amorphous solid dispersions: preformulation, formulation strategies, technological advancements and characterization. Pharmaceutics 2022;14:2203.","journal-title":"Pharmaceutics"},{"key":"6868_CR122","doi-asserted-by":"crossref","unstructured":"Yohana Chaerunisaa A, Sriwidodo S, Abdassah M. Microcrystalline cellulose as pharmaceutical excipient. In: Pharmaceutical formulation design\u2014recent practices. Rijeka: InTech; 2020.","DOI":"10.5772\/intechopen.88092"},{"key":"6868_CR123","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/lubricants2010021","volume":"2","author":"J Li","year":"2014","unstructured":"Li J, Wu Y. Lubricants in pharmaceutical solid dosage forms. Lubricants. 2014;2:21\u201343.","journal-title":"Lubricants"},{"key":"6868_CR124","doi-asserted-by":"publisher","unstructured":"Kanher PR. Lubricants in pharmaceutical solid dosage forms with special emphasis on magnesium stearate. World J Pharm Res. 2017;(9):131\u201346. https:\/\/doi.org\/10.20959\/wjpr20179-9170.","DOI":"10.20959\/wjpr20179-9170"},{"key":"6868_CR125","doi-asserted-by":"crossref","unstructured":"Kar M, Chourasiya Y, Maheshwari R, Tekade RK. Current developments in excipient science: implication of quantitative selection of each excipient in product development. In: Basic fundamentals of drug delivery. Academic Press; 2019. pp. 29\u201383.","DOI":"10.1016\/B978-0-12-817909-3.00002-9"},{"key":"6868_CR126","doi-asserted-by":"crossref","unstructured":"Yohana Chaerunisaa A, Sriwidodo S, Abdassah M. Microcrystalline cellulose as pharmaceutical excipient. In: Pharmaceutical formulation design - recent practices. IntechOpen: London; 2020.","DOI":"10.5772\/intechopen.88092"},{"key":"6868_CR127","doi-asserted-by":"crossref","first-page":"102504","DOI":"10.1016\/j.nano.2021.102504","volume":"40","author":"K Kourani","year":"2022","unstructured":"Kourani K, Jain P, Kumar A, Jangid AK, Swaminathan G, Durgempudi VR, et al. Inulin coated Mn3O4 nanocuboids coupled with RNA interference reverse intestinal tumorigenesis in Apc knockout murine colon cancer models. Nanomedicine 2022;40:102504.","journal-title":"Nanomedicine"},{"key":"6868_CR128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics13040576","volume":"13","author":"MA Reeves","year":"2021","unstructured":"Reeves MA, Royal JM, Morris DA, Jurkiewicz JM, Matoba N, Hamorsky KT. Spray-dried formulation of epicertin, a recombinant cholera toxin b subunit variant that induces mucosal healing. Pharmaceutics 2021;13:1\u201313.","journal-title":"Pharmaceutics"},{"key":"6868_CR129","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.2174\/1567201818666210127093327","volume":"18","author":"V Agrawal","year":"2021","unstructured":"Agrawal V, Sandal N, Singh AK, Pathak DP. pH-dependent release matrix oral formulation of Prussian blue to improve its efficacy as an internal decorporation agent. Curr Drug Deliv. 2021;18:1162\u201373.","journal-title":"Curr Drug Deliv"},{"key":"6868_CR130","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1080\/03639045.2017.1318896","volume":"43","author":"T Osmalek","year":"2017","unstructured":"Osmalek T, Milanowski B, Froelich A, Szybowicz M, Bialow\u0105s W, Kapela M, et al. Design and characteristics of gellan gum beads for modified release of meloxicam. Drug Dev Ind Pharm. 2017;43:1314\u201329.","journal-title":"Drug Dev Ind Pharm"},{"key":"6868_CR131","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1080\/03639045.2020.1844730","volume":"46","author":"MH Othman","year":"2020","unstructured":"Othman MH, Zayed GM, Ali UF, Abdellatif AAH. Colon-specific tablets containing 5-fluorouracil microsponges for colon cancer targeting. Drug Dev Ind Pharm. 2020;46:2081\u20138.","journal-title":"Drug Dev Ind Pharm"},{"key":"6868_CR132","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/nmat2859","volume":"9","author":"SD Wilson","year":"2010","unstructured":"Wilson SD, Dalmasso G, Wang L, Sitaraman SV, Merlin D, Murthy N. Orally delivered thioketal-nanoparticles loaded with TNF\u03b1-siRNA target inflammation and inhibit gene expression in the intestines. Nat Mater. 2010;9:923\u20138.","journal-title":"Nat Mater"},{"key":"6868_CR133","first-page":"692","volume":"8","author":"A Chauhan","year":"2019","unstructured":"Chauhan A, Rohilla S, Jain S. Direct compression method. World J Pharm Pharm Sci. 2019;8:692\u2013701.","journal-title":"World J Pharm Pharm Sci"},{"key":"6868_CR134","doi-asserted-by":"crossref","first-page":"104191","DOI":"10.1016\/j.jddst.2023.104191","volume":"80","author":"K Patil","year":"2023","unstructured":"Patil K, Dali P, Mangal N, Kathpalia H. An update on advancements in tablet tooling technology. J Drug Deliv Sci Technol. 2023;80:104191.","journal-title":"J Drug Deliv Sci Technol"},{"key":"6868_CR135","doi-asserted-by":"crossref","first-page":"55","DOI":"10.15171\/bi.2015.04","volume":"5","author":"S Shanmugam","year":"2015","unstructured":"Shanmugam S. Granulation techniques and technologies: recent progresses. BioImpacts 2015;5:55\u201363.","journal-title":"BioImpacts"},{"key":"6868_CR136","doi-asserted-by":"crossref","first-page":"118402","DOI":"10.1016\/j.powtec.2023.118402","volume":"421","author":"L Wang","year":"2023","unstructured":"Wang L, Zhao L, Hong Y, Shen L, Lin X. Technological advances and challenges for exploring attribute transmission in tablet development by high shear wet granulation. Powder Technol. 2023;421:118402.","journal-title":"Powder Technol"},{"key":"6868_CR137","first-page":"609","volume":"2","author":"AK Vadaga","year":"2024","unstructured":"Vadaga AK, Gudla SS, Nareboina GSK, Gubbala H, Golla B. Comprehensive review on modern techniques of granulation in pharmaceutical solid dosage forms. Intell Pharm. 2024;2:609\u201329.","journal-title":"Intell Pharm"},{"key":"6868_CR138","doi-asserted-by":"crossref","first-page":"117214","DOI":"10.1016\/j.powtec.2022.117214","volume":"399","author":"J Vanamu","year":"2022","unstructured":"Vanamu J, Sahoo A. An overview on dry powder coating in advancement to electrostatic dry powder coating used in pharmaceutical industry. Powder Technol. 2022;399:117214.","journal-title":"Powder Technol"},{"key":"6868_CR139","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.3390\/polym14163318","volume":"14","author":"A Salawi","year":"2022","unstructured":"Salawi A. Pharmaceutical coating and its different approaches, a review. Polymers. 2022;14:3318.","journal-title":"Polymers"},{"key":"6868_CR140","doi-asserted-by":"crossref","first-page":"144392","DOI":"10.1016\/j.cej.2023.144392","volume":"471","author":"J Chen","year":"2023","unstructured":"Chen J, Yang Q, Liu J, Jin M, He S, Zhou X, et al. Understanding the correlations between tablet flow dynamics and coating uniformity in a pan coater: experiments and simulations. Chem Eng J. 2023;471:144392.","journal-title":"Chem Eng J"},{"key":"6868_CR141","doi-asserted-by":"crossref","first-page":"7","DOI":"10.18231\/J.JOAPR.2022.7.14","volume":"10","author":"D Ganguly","year":"2022","unstructured":"Ganguly D, Ghosh S, Chakraborty P, Mitra S, Chatterjee S, Panja S, et al. A brief review on recent advancement of tablet coating technology. J Appl Pharm Res. 2022;10:7\u201314.","journal-title":"J Appl Pharm Res"},{"key":"6868_CR142","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cis.2015.05.003","volume":"223","author":"A Sosnik","year":"2015","unstructured":"Sosnik A, Seremeta KP. Advantages and challenges of the spray-drying technology for the production of pure drug particles and drug-loaded polymeric carriers. Adv Colloid Interface Sci. 2015;223:40\u201354.","journal-title":"Adv Colloid Interface Sci"},{"key":"6868_CR143","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev-chembioeng-091720-034106","volume":"12","author":"JM Baumann","year":"2021","unstructured":"Baumann JM, Adam MS, Wood JD. Engineering advances in spray drying for pharmaceuticals. Annu Rev Chem Biomol Eng. 2021;12:217\u201340.","journal-title":"Annu Rev Chem Biomol Eng"},{"key":"6868_CR144","doi-asserted-by":"crossref","first-page":"113840","DOI":"10.1016\/j.addr.2021.113840","volume":"178","author":"M Sohail Arshad","year":"2021","unstructured":"Sohail Arshad M, Zafar S, Yousef B, Alyassin Y, Ali R, AlAsiri A, et al. A review of emerging technologies enabling improved solid oral dosage form manufacturing and processing. Adv Drug Deliv Rev. 2021;178:113840.","journal-title":"Adv Drug Deliv Rev"},{"key":"6868_CR145","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1080\/07373930600734018","volume":"24","author":"H Sadikoglu","year":"2006","unstructured":"Sadikoglu H, Ozdemir M, Seker M. Freeze-drying of pharmaceutical products: research and development needs. Dry Technol. 2006;24:849\u201361.","journal-title":"Dry Technol"},{"key":"6868_CR146","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s43094-023-00551-8","volume":"9","author":"SR Pardeshi","year":"2023","unstructured":"Pardeshi SR, Deshmukh NS, Telange DR, Nangare SN, Sonar YY, Lakade SH, et al. Process development and quality attributes for the freeze-drying process in pharmaceuticals, biopharmaceuticals and nanomedicine delivery: a state-of-the-art review. Futur J Pharm Sci. 2023;9:99.","journal-title":"Futur J Pharm Sci"},{"key":"6868_CR147","doi-asserted-by":"crossref","unstructured":"Law Lim C, Mujumdar AS. Fluidized bed dryers. In: Mujumdar AS, editor. Handbook of industrial drying. Boca Raton: CRC Press; 2006.","DOI":"10.1201\/9781420017618"},{"key":"6868_CR148","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.partic.2018.05.002","volume":"42","author":"LAP de Freitas","year":"2019","unstructured":"de Freitas LAP. Pharmaceutical applications of spouted beds: a review on solid dosage forms. Particuology 2019;42:126\u201336.","journal-title":"Particuology"},{"key":"6868_CR149","unstructured":"Lubrizol Corporation. Emulsions and Emulsifications [Internet]. Cleveland; 2019 [cited 2025]. Available from: https:\/\/lubrizolcdmo.com\/wp-content\/uploads\/2019\/10\/TB-9-Emulsions-and-Emulsification_lowres.pdf."},{"key":"6868_CR150","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jconrel.2021.08.013","volume":"337","author":"I Maji","year":"2021","unstructured":"Maji I, Mahajan S, Sriram A, Medtiya P, Vasave R, Khatri DK, et al. Solid self emulsifying drug delivery system: Superior mode for oral delivery of hydrophobic cargos. J Control Release. 2021;337:646\u201360.","journal-title":"J Control Release"},{"key":"6868_CR151","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1517\/17425247.2011.598147","volume":"8","author":"P Srinarong","year":"2011","unstructured":"Srinarong P, De Waard H, Frijlink HW, Hinrichs WLJ. Improved dissolution behavior of lipophilic drugs by solid dispersions: the production process as starting point for formulation considerations. Expert Opin Drug Deliv. 2011;8:1121\u201340.","journal-title":"Expert Opin Drug Deliv"},{"key":"6868_CR152","doi-asserted-by":"crossref","first-page":"102452","DOI":"10.1016\/j.jddst.2021.102452","volume":"63","author":"S Tambe","year":"2021","unstructured":"Tambe S, Jain D, Agarwal Y, Amin P. Hot-melt extrusion: highlighting recent advances in pharmaceutical applications. J Drug Deliv Sci Technol. 2021;63:102452.","journal-title":"J Drug Deliv Sci Technol"},{"key":"6868_CR153","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1208\/s12249-020-01854-2","volume":"21","author":"DK Tan","year":"2020","unstructured":"Tan DK, Davis DA, Miller DA, Williams RO, Nokhodchi A. Innovations in thermal processing: hot-melt extrusion and KinetiSol\u00ae dispersing. AAPS PharmSciTech. 2020;21:312.","journal-title":"AAPS PharmSciTech"},{"key":"6868_CR154","doi-asserted-by":"crossref","unstructured":"Kapoor D, Maheshwari R, Verma K, Sharma S, Ghode P, Tekade K. Coating technologies in pharmaceutical product development. In: Drug delivery systems. Academic Press; 2020. pp. 665\u2013719.","DOI":"10.1016\/B978-0-12-814487-9.00014-4"},{"key":"6868_CR155","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1080\/17425247.2017.1289173","volume":"14","author":"M Champeau","year":"2017","unstructured":"Champeau M, Thomassin JM, Tassaing T, J\u00e9r\u00f4me C. Current manufacturing processes of drug-eluting sutures. Expert Opin Drug Deliv. 2017;14:1293\u2013303.","journal-title":"Expert Opin Drug Deliv"}],"container-title":["Journal of Materials Science: Materials in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10856-025-06868-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10856-025-06868-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10856-025-06868-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T20:02:55Z","timestamp":1767643375000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10856-025-06868-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":155,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6868"],"URL":"https:\/\/doi.org\/10.1007\/s10856-025-06868-5","relation":{},"ISSN":["1573-4838"],"issn-type":[{"value":"1573-4838","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,5]]},"assertion":[{"value":"14 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"24"}}